General AML,   FLT3

Richard Stone | EBMT 2019 | Role of FLT3 inhibitors in the treatment landscape of AML

L:

45th Annual Meeting of the EBMT, 24—27 March 2019, Frankfurt, DE

Richard Stone

Dana-Farber Cancer Institute, Boston, US

Download this article:

You can now download this article in Adobe PDF® format.

Download as PDF